Association of liver disease with obesity in people having diabetics.

Not yet recruiting

Conditions: Fatty (change of) liver, not elsewhere classified, (2) ICD-10 Condition: E669||Obesity, unspecified, (3) ICD-10 Condition: E118||Type 2 diabetes mellitus with unspecified complications,

Brief Summary: In India, there is lack of data regarding prevalance of NAFLD in diabetics and its further link to obesity. Diabetes and obesity have been proven to be independent risk factors for NAFLD, but both are commonly found together. The interplay between diabetes, NAFLD and obesity needs to be studied in detail. Hence, this study is planned to study the prevalance of NAFLD in obese and non-obese diabetics.

Recruitment & Eligibility

Inclusion Criteria

Type 2 Diabetes.

Exclusion Criteria

1)History of alcohol intake (more than 20 gms in per day in males and more then 10 gms per day in females).
2)Chronic liver disease like Hepatitis C and Hepatitis B, Autoimmune hepatitis.
3)History of taking drugs known to cause fatty liver disease E.g. Amidarone, tamoxifen, Glucocorticoids, Esterogens.
4)Recent and past illness known to cause NAFLD like protein energy malnutrition, starvation, patient on Total parenternal nutrition , Gastrointestinal surgery for obesity, inflammatory bowel disease, Wilson disease .

Primary Outcome Measures

Name	Time	Method
Prevalence of NAFLD in patients of type2 diabetes mellitus.	1 Day

Secondary Outcome Measures

Name	Time	Method
Association between obesity and NAFLD in diabetics	1 Day

Locations (1): Batra Hospital and Medical Research Centre
🇮🇳
Delhi, DELHI, India
Batra Hospital and Medical Research Centre
🇮🇳Delhi, DELHI, India
Shashank Bhardwaj
Principal investigator
8920744429
shashank.bhrdwaj@gmail.com